European Pharmaceutical Review

SEPTEMBER 22, 2023

Limitations of monoclonal antibody therapies Regulatory approvals from the US Food and Drug Administration (FDA) for aducanumab and lecanemab – and likely very soon for donanemab also – opened a route for different therapeutic modalities and other relevant disease targets, such as tau.

Food and Drug Administration 76

Food and Drug Administration Safety Patients Leads 76

Pharmaceutical Technology

DECEMBER 21, 2022

This could spell high-stake consequences for consumers whose privacy and safety could be at risk if AI models are not regulated. As of June 2021 , companies such as Bristol Myers Squibb , Bayer and Pfizer led the AI deals space for the pharmaceutical sectors. FDA and EMA action. Major AI deals in 2022.

Pharma 140

Pharma Pharmaceutical Medicine Government 140

Pharmaceutical Technology

APRIL 12, 2023

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. Globally, non-human primates make up a relatively small percentage of the animals used in research. In 2021, they accounted for 0.2% The FDA’s Modernization Act 2.0

Pharma 98

Pharma Food and Drug Administration Safety Medicine 98

Pharmaceutical Technology

MARCH 6, 2023

Currently, most drugs being investigated for their healthy aging or anti-aging properties are being repurposed from readily accessible FDA-approved drugs. Barzilai hopes that the well-established profile of the drug may allow the FDA to accept the trial more easily and then other aging-related studies can follow.

FDA 145

FDA Pharmaceutical Prospecting Medicine 145